Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price

Datum : 11/02/2019 @ 13h57
Quelle : Dow Jones News
Name : Sanofi (SAN)
Kurs : 87.53  -0.98 (-1.11%) @ 17h40
Sanofi share price Chart

Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart

Von Mai 2018 bis Mai 2020

Click Here for more Regeneron Pharmaceuticals Charts.

By Michael Dabaie


Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) said Monday they will offer Praluent at a reduced U.S. list price.

Praluent will be available at a reduced U.S. list price of $5,850 annually, a 60% reduction from the original price, for both the 75 mg and 150 mg doses, beginning in early March.

With the new lower-priced Praluent, most Medicare Part D patients are expected to pay between $25 to $150 per month, depending on their insurance plan, the companies said. Praluent is a treatment for adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease.

The companies in March 2018 committed to lower the U.S. net price for payers in return for helping to reduce access barriers for appropriate patients, the companies said.


Write to Michael Dabaie at


(END) Dow Jones Newswires

February 11, 2019 07:42 ET (12:42 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Kürzlich von Ihnen besucht
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
P: V:de D:20200531 10:08:14